Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07287553

Dietary Inflammatory Index and Periodontal Status in Obese Patients

The Relationship Between Dietary Inflammatory Index and Periodontal Status in Obese Patients

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Recep Tayyip Erdogan University Training and Research Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers

Summary

In this study aimed to investigate the effect of nutrition on periodontal status in individuals diagnosed with obesity and without any other systemic disease, and to investigate the relationship between DII and periodontal disease risk. A total of 200 participants will be included in the study. Participants' overall daily Dietary Inflammatory Index (DII) scores will be calculated. The obtained scores will be divided into four groups, from low to high: Q1 (n=50), Q2 (n=50), Q3 (n=50), and Q4 (n=50). According to the DII, groups Q1 and Q2, which include lower scores, represent individuals on an anti-inflammatory diet, while groups Q3 and Q4, which include higher scores, represent individuals on a pro-inflammatory diet. Interleukin (IL)-1β, IL-10, total oxidant status (TOS), and total antioxidant status (TAS) were collected from gingival crevicular fluid (GCF) and serum samples. The levels of biomarkers such as malondialdehyde (MDA), glutathione (GSH), leptin, adiponectin, tumor necrosis factor (TNF)-α and C-reactive protein (CRP) from serum samples alone will be analyzed by ELISA method at the Recep Tayyip Erdoğan University Medical Biochemistry Laboratory.

Conditions

Interventions

TypeNameDescription
OTHERPeriodontal indices will be obtainedPeriodontal indices will be obtained from all participants
OTHERserum and crevicular fluid samples will be collectedSerum and gingival crevicular fluid samples will be collected from all participants.

Timeline

Start date
2025-11-22
Primary completion
2026-02-21
Completion
2026-03-21
First posted
2025-12-17
Last updated
2025-12-17

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07287553. Inclusion in this directory is not an endorsement.